May 13, 2008 | PR-inside.com
Ibuprofen or Aspirin? Choosing Can Give You A Headache
These over-the-counter drugs can do wonders, but which to choose? And what's the downside? They're both non-prescription pain killers, and they're recommended for everything from headaches to breast cancer to ... via PR-inside.com
Pseudogout mimics gout but isn't
Dear Dr. Donohue: All of a sudden my left knee blew up on me. It was swollen, red and hot. via HeraldTribune.com
[Cardiology Patient Page] Can Patients With Cardiovascular Disease...
From the Department of Science and Medicine, American Heart Association, Dallas, Tex. via Circulation
Gout: Through the years, a case of real misery
Suffering from a very painful foot, the patient looked miserable. The foot suddenly began to hurt, followed by rapid swelling with redness on the large toe. via Great Falls Tribune
Gout is a disorder characterized by too much uric acid in the blood and tissues. via InteliHealth
Anti-Inflammatories Ward Off Parkinson's: Study
“The results of postmortem studies suggest that inflammation is involved in the development of Parkinson's disease and there is experimental evidence that NSAIDs are protective for the cells that are selectively destroyed”
Tuesday April 01, 2008 ISLAMABAD: Regular use of anti-inflammatory drugs appears to lower the risk of developing Parkinson's disease, perhaps by protecting brain cells that would otherwise die, researchers ... via PakTribune
Klobuchar questions cost of drug for premature babies
“The alternative would be surgery”
Sophia Benson and her twin sister were born 12 weeks early in November 2006. Sophia was diagnosed with patent ductus arteriosus, a disorder that prevents holes in the hears of babies from healing. via TwinCities
In curious kind of arthritis, joints 'react' to an infection
DEAR DR. DONOHUE: My son, 25, contracted a food-borne bacterial infection this summer in Egypt. via SouthCoastToday.com
Topical anti-inflammatory activity of Polygonum cuspidatum extract in ...
This study tested the ability of a characterized extract of Polygonum cuspidatum to inhibit mouse ear inflammation in response to topical application of 12-O-tetradecanoylphorbol-13-acetate . Methods A 50% ... via Journal of Inflammation
Analgesic effect of percutaneously absorbed non-steroidal...
External medication that is absorbed percutaneously may be used to reduce inflammation and relieve pain from acute injuries such as ankle sprains and bruises. via BMC Musculoskeletal Disorders
A mix of connective-tissue woes
Dear Dr. Donohue: I was diagnosed with mixed connective-tissue disease more than 10 years ago. via HeraldTribune.com
'Mixed' disease affects many kinds of connective tissues
DEAR DR. DONOHUE: I was diagnosed with mixed connective tissue disease more than 10 years ago. via SouthCoastToday.com
Ministry Bans Five Traditional Medicines
The Ministry of Health has come forward quickly to advise the public against purchasing several traditional medicines following recalls made by drug authorities in neighbouring countries. via BruDirect
Pre-term labor drug may harm baby
There's important news for pregnant women. A drug commonly used during pre-term labor may cause harm to the baby. via WHEC10
What to do when stomach can't tolerate arthritis drugs
DEAR DR. DONOHUE: I am a 54-year-old female who was on anti-inflammatory medicines, including Aleve and Advil, for approximately three years for back and knee pain. via SouthCoastToday.com
Savient Travels Gout Route; Phase III Results Due Shortly
“Puricase remains one of our favorite products in development in the space today, with favorable prospects for both regulatory and commercial success”
As a therapeutic indication, rheumatoid arthritis gets more love from investors, but another painful joint disorder has come to the fore as well, and Savient Pharmaceuticals Inc. via BioWorld
Sucampo Pharmaceuticals Presents Data on Cobiprostone at American...
“These data strongly suggest that activation of chloride channels underlie the protective effects of cobiprostone against NSAID-induced cellular damage”
Scott Solomon, 617-542-5300 Vice President ssolomon@investorrelations.com Sucampo Pharmaceuticals, Inc., today announced the presentation of a scientific poster addressing the potential ability of its clinical ... via PR-inside.com